Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Andrew Roberts

University of Melbourne

Research Interests

Explore related searches

Articles (22)

Collaborators (6)

Nadia Davidson

Laboratory Head

Walter and Eliza Hall Institute

Monica Slavin

University of Melbourne

Michelle Yong

University of Melbourne

Jafar S. Jabbari

Senior Researcher, Genomics Innovation and Development

Walter and Eliza Hall Institute of Medical Research

Gianluca GAIDANO

Professor of Hematology

Daniel Gray

Joint Division Head and Laboratory Head

Walter and Eliza Hall Institute of Medical Research

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andrew Roberts

Research Interests

Explore related searches

Articles (22)

Collaborators (6)

Nadia Davidson

Monica Slavin

Michelle Yong

Jafar S. Jabbari

Gianluca GAIDANO

Daniel Gray

Make your next move.

Andrew Roberts

Research Interests

Explore related searches

Articles (22)

Myeloid/lymphoid neoplasms with eosinophilia and ZMYM2::FLT3 fusion: clinical, pathological and molecular clues to a cryptic diagnosis

Blood: flowing stronger than ever after 80 years

Resistance to targeted therapies in chronic lymphocytic leukemia: Current status and perspectives for clinical and diagnostic practice

Antifungal prophylaxis in patients with FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD)–positive acute myeloid leukaemia receiving sorafenib during initial induction and consolidation treatment in ALLG AMLM16 trial

Emergent BAX-mutated clonal hematopoiesis after venetoclax-based therapy for breast cancer

A single‐institution study of allograft outcomes for chronic lymphocytic leukaemia over 20 years

Enterocolitis associated with glofitamab—First report and clinicopathological findings in three cases

Final analysis of the phase 1b Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT)

Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteins

Retreatment with venetoclax and rituximab following disease progression while off therapy in patients with chronic lymphocytic leukemia

Routine magnetic resonance central nervous system imaging may be avoided in high-risk systemic diffuse large B-cell lymphoma with negative cerebrospinal fluid analyses

Single-cell Rapid Capture Hybridization sequencing reliably detects isoform usage and coding mutations in targeted genes

Acute leukaemia in Australia: outcomes have improved, but there is still much to do

Acute leukaemia in Australia: outcomes have improved, but there is still much to do

Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies

Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies

Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach COMMENT

Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL

Germline MBD4 deficiency causes a multi-tumor predisposition syndrome

Single-cell sequencing demonstrates complex resistance landscape in CLL and MCL treated with BTK and BCL2 inhibitors

BCL2 and MCL1 inhibitors for hematologic malignancies

BCL2 and MCL1 inhibitors for hematologic malignancies

Collaborators (6)

Nadia Davidson

Monica Slavin

Michelle Yong

Jafar S. Jabbari

Gianluca GAIDANO

Daniel Gray

Make your next move.